An American Sickness: How Healthcare Became Big Business and How You Can Take It Back

by Elisabeth Rosenthal

The number of pay-for-delay arrangements has increased dramatically since 2010, and the result is no generic drug competition to produce cheaper alternative versions for a growing number of brand-name drugs.